Emergent BioSolutions (EBS) Change in Inventory (2010 - 2026)

Emergent BioSolutions' Change in Inventory history runs 17 years deep, the most recent figure standing at -$15.8 million for Q1 2026.

• On a quarterly basis, Change in Inventory fell 818.18% year-over-year to -$15.8 million in Q1 2026; TTM through Mar 2026 was $12.3 million, a 44.59% decrease from a year earlier, with the FY2025 full-year figure at $30.3 million, up 23.67% from the prior year.
• Change in Inventory slipped to -$15.8 million in Q1 2026 per EBS's latest filing, from -$14.2 million in the prior quarter.
• Across five years, Change in Inventory topped out at $50.1 million in Q1 2022 and bottomed at -$127.7 million in Q4 2022.
• The 5-year median for Change in Inventory is $4.5 million (2024), against an average of $794117.6.
• Across the five-year window, Change in Inventory tumbled 1584.88% in 2022 and jumped 17900.0% in 2024, its largest moves.
• Year by year, Change in Inventory stood at -$127.7 million in 2022, then soared by 79.95% to -$25.6 million in 2023, then jumped by 57.03% to -$11.0 million in 2024, then dropped by 29.09% to -$14.2 million in 2025, then decreased by 11.27% to -$15.8 million in 2026.
• Per Business Quant, the three latest EBS Change in Inventory figures stand at -$15.8 million (Q1 2026), -$14.2 million (Q4 2025), and $17.6 million (Q3 2025).